GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Purchase Of Business

OKUR (OnKure Therapeutics) Purchase Of Business : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Purchase Of Business?

OnKure Therapeutics's purchase of business for the three months ended in Sep. 2024 was $0.00 Mil. It means OnKure Therapeutics spent $0.00 Mil on purchasing business. OnKure Therapeutics's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2024 ), OnKure Therapeutics spent the same money on purchasing business in Sep. 2024 ($0.00 Mil).


OnKure Therapeutics Purchase Of Business Historical Data

The historical data trend for OnKure Therapeutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Purchase Of Business Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23
Purchase Of Business
- -

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Business Get a 7-Day Free Trial - - - - -

OnKure Therapeutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OnKure Therapeutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


OnKure Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.